These signals were further validated using follow-up data from 1,203 Chinese coronary heart disease (CHD) patients treated with PCSK9 inhibitors.<h4>Results</h4>A total of 173,622 reports involving at least one PCSK9 inhibitor were identified in FAERS. This evidence concerns the gene PCSK9 and coronary artery disorder.